• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潮热。睾丸切除术治疗前列腺癌的长期副作用。

Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.

作者信息

Charig C R, Rundle J S

机构信息

Institute of Urology, London, England.

出版信息

Urology. 1989 Mar;33(3):175-8. doi: 10.1016/0090-4295(89)90385-3.

DOI:10.1016/0090-4295(89)90385-3
PMID:2465644
Abstract

Orchiectomy is considered a safe and simple procedure, free from serious side effects, in the treatment of prostatic carcinoma. We have found that 76 percent of patients experienced postorchiectomy flushes, and 30 percent believed their symptoms warranted treatment. The flushing started at between one and twelve months (average 2.7 months) postoperatively and lasted an average of thirty months or, in some cases, up to the time of death (average 33 months). No single precipitating factor was found, and no single hormone seemed to be responsible. Special attention was given to the nonflushers to see whether or not it was of prognostic significance, and it appears that the slight elevation in the testosterone level sufficient to prevent flushing may indicate a nontesticular source of androgen. Medroxyprogesterone acetate (Provera), 5 mg twice daily, appeared to be an effective agent for controlling the flushes.

摘要

睾丸切除术在前列腺癌治疗中被认为是一种安全、简单的手术,且无严重副作用。我们发现,76%的患者在睾丸切除术后出现潮热,30%的患者认为其症状需要治疗。潮热在术后1至12个月(平均2.7个月)开始,平均持续30个月,在某些情况下,直至死亡(平均33个月)。未发现单一的诱发因素,似乎也没有单一激素对此负责。我们对未出现潮热的患者给予了特别关注,以观察这是否具有预后意义,似乎足以防止潮热的睾酮水平轻微升高可能表明雄激素的非睾丸来源。醋酸甲羟孕酮(安宫黄体酮),每日两次,每次5毫克,似乎是控制潮热的有效药物。

相似文献

1
Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.潮热。睾丸切除术治疗前列腺癌的长期副作用。
Urology. 1989 Mar;33(3):175-8. doi: 10.1016/0090-4295(89)90385-3.
2
The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.
Int Urol Nephrol. 1988;20(2):131-7. doi: 10.1007/BF02550662.
3
[Cyproterone acetate in the treatment of post-orchiectomy flushing].醋酸环丙孕酮治疗睾丸切除术后潮热
Ugeskr Laeger. 1989 Feb 27;151(9):560-1.
4
Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone.己烯雌酚治疗睾丸切除术后血管舒缩症状及其与血清促卵泡激素、促黄体生成素和睾酮的关系。
Urology. 1992 Feb;39(2):108-10. doi: 10.1016/0090-4295(92)90264-w.
5
Pituitary function after orchiectomy in patients with or without earlier estrogen treatment for prostatic carcinoma.
J Endocrinol Invest. 1987 Oct;10(5):479-82. doi: 10.1007/BF03348174.
6
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.大剂量醋酸甲羟孕酮对晚期前列腺癌患者血浆激素水平及疼痛缓解的影响。
Br J Urol. 1990 Mar;65(3):278-81. doi: 10.1111/j.1464-410x.1990.tb14727.x.
7
[High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Wien Klin Wochenschr. 1987 Oct 9;99(19):682-6.
8
Management of hot flushes due to endocrine therapy for prostate carcinoma.前列腺癌内分泌治疗引起的潮热的管理。
Oncology (Williston Park). 1996 Sep;10(9):1319-22; discussion 1324.
9
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.长效促性腺激素释放激素激动剂联合醋酸甲羟孕酮治疗子宫内膜异位症。
Obstet Gynecol. 1990 Apr;75(4):641-5.
10
[Effect of medroxyprogesterone (MPA) on blood levels of FSH, LH and prolactin in women].
Ginekol Pol. 1985 Oct;56(10):581-4.

引用本文的文献

1
The Association Between Hot Flashes and Renal Dysfunction After Androgen Deprivation Therapy With Radiotherapy in Japanese Patients With High-risk Prostate Cancer.日本高危前列腺癌患者接受雄激素剥夺治疗联合放射治疗后热潮红与肾功能障碍的相关性。
In Vivo. 2021 Nov-Dec;35(6):3489-3493. doi: 10.21873/invivo.12650.
2
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience.评估接受激素治疗的前列腺癌患者血管舒缩症状和心理症状的患病率及预测因素:单机构经验结果
Clin Transl Radiat Oncol. 2018 Mar 21;10:29-35. doi: 10.1016/j.ctro.2018.03.002. eCollection 2018 Mar.
3
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
《生存指南》,2017年第2版,美国国立综合癌症网络(NCCN)肿瘤临床实践指南
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.
4
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.对更年期和癌症患者血管舒缩症状非激素治疗的系统评价。
Springerplus. 2015 Feb 10;4:65. doi: 10.1186/s40064-015-0808-y. eCollection 2015.
5
How long do the effects of acupuncture on hot flashes persist in cancer patients?针刺治疗对癌症患者热潮红的疗效能持续多久?
Support Care Cancer. 2014 May;22(5):1409-15. doi: 10.1007/s00520-014-2126-2. Epub 2014 Jan 30.
6
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.随机试验评估文拉法辛和大豆蛋白对前列腺癌男性热潮红及生活质量的影响。
J Clin Oncol. 2013 Nov 10;31(32):4092-8. doi: 10.1200/JCO.2012.48.1432. Epub 2013 Sep 30.
7
The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.激素治疗下癌症患者非雌激素类疗法治疗热潮红的疗效:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2013 Oct;139(10):1701-7. doi: 10.1007/s00432-013-1491-4. Epub 2013 Aug 23.
8
The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.支持性护理在优化晚期前列腺癌患者治疗效果中的重要性。
Oncologist. 2012;17 Suppl 1(Suppl 1):23-30. doi: 10.1634/theoncologist.2012-S1-23.
9
Hot flashes: a review of pathophysiology and treatment modalities.热潮红:病理生理学和治疗方式的综述。
Oncologist. 2011;16(11):1658-64. doi: 10.1634/theoncologist.2011-0174. Epub 2011 Oct 31.
10
Mechanism of hot flashes.热潮的机制。
Clin Transl Oncol. 2011 Mar;13(3):143-7. doi: 10.1007/s12094-011-0633-x.